Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hangping Yao and Yunqing Qiu.
Hangping Yao
Connection Strength
0.445
Yunqing Qiu
  1. Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial. Eur J Pharm Sci. 2021 Feb 01; 157:105631.
    View in: PubMed
    Score: 0.227
  2. Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies. Biotechnol J. 2021 Nov; 16(11):e2100207.
    View in: PubMed
    Score: 0.060
  3. Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site. Emerg Microbes Infect. 2020 Dec; 9(1):1474-1488.
    View in: PubMed
    Score: 0.057
  4. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 04 21; 369:m1443.
    View in: PubMed
    Score: 0.055
  5. Open-label phase I clinical trial of Ad5-EBOV in Africans in China. Hum Vaccin Immunother. 2017 09 02; 13(9):2078-2085.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.